
FDA Approves Adaptive DBS for Parkinson’s
In a truly groundbreaking moment for neurological care, the U.S. Food and Drug Administration (FDA) recently greenlit Medtronic’s BrainSense Adaptive deep brain stimulation (aDBS) system. This isn’t just another incremental upgrade; it represents a significant, […]